ERBB2 and breast carcinoma: Another breast cancer driver, GATA3, shifts gene expression towards the face defined by the lipogenic, HER2 and invasion and tissue remodeling tasks and away from the cell division archetype (p = 0.003, hypergeometric test, Fig. 3f).